D61.810

Antineoplastic chemotherapy induced pancytopenia

Billable / specific

D61.810 is a billable, specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes in FY2027.

Excludes1

Not coded here — never report together with this code.

pancytopenia (due to) (with) aplastic anemia (D61.9) (from D61.81)
pancytopenia (due to) (with) bone marrow infiltration (D61.82) (from D61.81)
pancytopenia (due to) (with) congenital (pure) red cell aplasia (D61.01) (from D61.81)
pancytopenia (due to) (with) hairy cell leukemia (C91.4-) (from D61.81)
pancytopenia (due to) (with) human immunodeficiency virus disease (B20.-) (from D61.81)
pancytopenia (due to) (with) leukoerythroblastic anemia (D61.82) (from D61.81)
pancytopenia (due to) (with) myeloproliferative disease (D47.1) (from D61.81)

Not included here — may be reported together when both conditions exist.

aplastic anemia due to antineoplastic chemotherapy (D61.1)
pancytopenia (due to) (with) myelodysplastic syndromes (D46.-) (from D61.81)
autoimmune disease (systemic) NOS (M35.9) (from D61)
certain conditions originating in the perinatal period (P00-P96) (from D61)
complications of pregnancy, childbirth and the puerperium (O00-O9A) (from D61)
congenital malformations, deformations and chromosomal abnormalities (Q00-Q99) (from D61)
endocrine, nutritional and metabolic diseases (E00-E88) (from D61)
human immunodeficiency virus [HIV] disease (B20) (from D61)
injury, poisoning and certain other consequences of external causes (S00-T88) (from D61)
neoplasms (C00-D49) (from D61)
symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94) (from D61)
neutropenia (D70.-) (from D61)